1 |
Feng Z, Xu QS, Qin LZ, et al. Predicting radiotherapy necessity in tongue cancer using lymph node yield[J]. J Oral Maxillofac Surg, 2017, 75(5): 1062-1070.
|
2 |
孙小雅, 严汉兴, 贺莎, 等. 舌癌多种治疗方式的临床疗效比较[J]. 中南医学科学杂志, 2018, 46(1): 16-19.
|
|
Sun XY, Yan HX, He S, et al. The comparison of the clinical curative effect of various treatments for tongue carcinoma[J]. Med Sci J Central South Chin, 2018, 46(1): 16-19.
|
3 |
Wherlock M, Mellor H. The Rho GTPase family: a Racs to Wrchs story[J]. J Cell Sci, 2002, 115(Pt 2): 239-240.
|
4 |
Burridge K, Wennerberg K. Rho and Rac take center stage[J]. Cell, 2004, 116(2): 167-179.
|
5 |
Garavini H, Riento K, Phelan JP, et al. Crystal structure of the core domain of RhoE/Rnd3: a constitutively activated small G protein[J]. Biochemistry, 2002, 41(20): 6303-6310.
|
6 |
Basbous S, Azzarelli R, Pacary E, et al. Pathophysiological functions of Rnd proteins[J]. Small GTPases, 2020: 1-22.
|
7 |
Paysan L, Piquet L, Saltel F, et al. Rnd3 in cancer: a review of the evidence for tumor promoter or suppressor[J]. Mol Cancer Res, 2016, 14(11): 1033-1044.
|
8 |
Riou P, Villalonga P, Ridley AJ. Rnd proteins: multifunctional regulators of the cytoskeleton and cell cycle progression[J]. Bioessays, 2010, 32(11): 986-992.
|
9 |
许良中, 杨文涛. 免疫组织化学反应结果的判断标准[J]. 中国癌症杂志, 1996, 6(4): 229-231.
|
|
Xu LZ, Yang WT. Criteria for judging the results of immunohistochemistry reaction[J]. Chin Oncol, 1996, 6(4): 229-231.
|
10 |
Foster R, Hu KQ, Lu Y, et al. Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation[J]. Mol Cell Biol, 1996, 16(6): 2689-2699.
|
11 |
Hernández-Sánchez M, Poch E, Guasch RM, et al. RhoE is required for contact inhibition and negatively regulates tumor initiation and progression[J]. Oncotarget, 2015, 6(19): 17479-17490.
|
12 |
Bektic J, Pfeil K, Berger AP, et al. Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis[J]. Prostate, 2005, 64(4):332-340.
|
13 |
Raz DJ, Ray MR, Kim JY, et al. A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma[J]. Clin Cancer Res, 2008, 14(17): 5565-5570.
|
14 |
Zhao H, Yang J, Fan T, et al. RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway[J]. Tumour Biol, 2012, 33(5): 1363-1374.
|
15 |
Ma W, Wong CC, Tung EK, et al. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway[J]. Hepatology, 2013, 57(1): 152-161.
|
16 |
Feng B, Li K, Zhong H, et al. RhoE promotes metastasis in gastric cancer through a mechanism dependent on enhanced expression of CXCR4[J]. PLoS One, 2013, 8(11): e81709.
|
17 |
Belgiovine C, Frapolli R, Bonezzi K, et al. Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells[J]. PLoS One, 2010, 5(11): e14154.
|
18 |
Nishizawa T, Nakano K, Harada A, et al. DGC-specific RHOA mutations maintained cancer cell survival and promoted cell migration via ROCK inactivation[J]. Oncotarget, 2018, 9(33): 23198-23207.
|
19 |
Shao Y, Tong Z, Wei J, et al. LncRNA-zinc finger protein 281 downregulates rho-associated coiled-coil containing protein kinase 1 by upregulating miR-144 in osteosarcoma[J]. Oncol Lett, 2020, 20(4): 79.
|
20 |
Jiang Y, Hong D, Lou Z, et al. Lupeol inhibits migration and invasion of colorectal cancer cells by suppressing RhoA-ROCK1 signaling pathway[J]. Naunyn Schmiedebergs Arch Pharmacol, 2020, 393(11): 2185-2196.
|
21 |
Piquet L, Robbe T, Neaud V, et al. Rnd3/RhoE expression is regulated by G-actin through MKL1-SRF signaling pathway[J]. Exp Cell Res, 2018, 370(2): 227-236.
|
22 |
Riento K, Ridley AJ. Inhibition of ROCK by RhoE[J]. Methods Enzymol, 2006, 406: 533-541.
|
23 |
Nishizuka M, Komada R, Imagawa M. Knockdown of RhoE expression enhances TGF-β-induced EMT (epithelial-to-mesenchymal transition) in cervical cancer HeLa cells[J]. Int J Mol Sci, 2019, 20(19): 4697.
|
24 |
柳海, 李秀, 吴强, 等. 口腔鳞状细胞癌中MMP9、CD-44v6表达及其意义[J]. 中国肿瘤, 2005, 14(11): 747-750.
|
|
Liu H, Li X, Wu Q, et al. The expression of matrix metalloproteinase-9 and CD44 splice variant 6 in oral squamous cell carcinoma and its significance[J]. Chin Cancer, 2005,14(11): 747-750.
|
25 |
Ma XL, Li X, Tian FJ, et al. Upregulation of RND3 affects trophoblast proliferation, apoptosis, and migration at the maternal-fetal interface[J]. Front Cell Dev Biol, 2020, 8: 153.
|
26 |
Zhou J, Li K, Gu Y, et al. Transcriptional up-regulation of RhoE by hypoxia-inducible factor (HIF)-1 promotes epithelial to mesenchymal transition of gastric cancer cells during hypoxia[J]. Biochem Biophys Res Commun, 2011, 415(2): 348-354.
|